Finance

Beta
Lists
688319:SHA
Chengdu Olymvax Biopharmaceuticals Inc
CN¥35.19
+3.29%
(+1.12) 1D
Jun 11, 3:00:03 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 688319...
Open
CN¥33.64
High
CN¥36.42
Low
CN¥33.30
Mkt. cap
13.82B
Avg. vol.
11.78M
Volume
10.21M
P/E ratio
252.46
52-wk high
CN¥41.63
52-wk low
CN¥15.41
EPS
CN¥0.14
No. of employees
451
Open
CN¥33.64
High
CN¥36.42
Low
CN¥33.30
Mkt. cap
13.82B
Avg. vol.
11.78M
Volume
10.21M
P/E ratio
252.46
52-wk high
CN¥41.63
52-wk low
CN¥15.41
EPS
CN¥0.14
No. of employees
451
News stories
From sources across the web
About Chengdu Olymvax Biopharmaceuticals Inc
CEO-
Employees451
FoundedDec 11, 2009
Headquarters-
SectorBiotechnology
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
218.36M
201.07M
197.24M
157.80M
Cost of goods sold
14.65M
14.60M
28.17M
12.87M
Cost of revenue
14.65M
14.60M
28.17M
12.87M
Research and development expenses
29.65M
36.10M
38.02M
20.19M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
113.55M
118.36M
159.56M
96.59M
Operating expense
180.63M
139.35M
197.40M
115.38M
Total operating expenses
195.28M
153.95M
225.57M
128.25M
Operating income
23.08M
47.12M
-28.33M
29.55M
Other non operating income
250.72K
-471.53K
365.44K
-2.89M
EBT including unusual items
21.72M
41.07M
-23.86M
32.42M
EBT excluding unusual items
19.81M
43.58M
-31.86M
26.79M
Income tax expense
1.45M
7.15M
1.39M
5.22M
Effective tax rate
6.69%
17.41%
-5.84%
16.11%
Other operating expenses
1.97M
828.21K
2.75M
-1.40M
Net income
20.27M
34.28M
-25.22M
27.19M
Net profit margin
9.28%
17.05%
-12.79%
17.23%
Earnings per share
-
-
-
-
Interest and investment income
275.72K
235.35K
290.12K
125.14K
Interest expense
-3.79M
-3.30M
-4.17M
-
Net interest expenses
-3.52M
-3.07M
-3.88M
125.14K
Depreciation and amortization charges
-
-
-
-
EBITDA
31.04M
54.11M
-19.96M
37.92M
Gain or loss from assets sale
-8.71K
8.71K
-8.71K
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more